Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Stifel Maintains Buy on Sea, Lowers Price Target to $105

Stifel analyst Scott Devitt maintains Sea (NYSE:SE) with a Buy and lowers the price target from $115 to $105.

byBenzinga Newsdesk

July 15, 2022

1 minute read

Stifel analyst Scott Devitt maintains Sea (NYSE:SE) with a Buy and lowers the price target from $115 to $105.

Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition

By Vandana Singh

Today, 5:56 AM

Sanofi SA (NASDAQ: SNY) has agreed to buy Austrian group Origi

BNTX

SVB Leerink Maintains Outperform on Kura Oncology, Raises Price Target to $41

By Benzinga Newsdesk

Today, 5:56 AM

SVB Leerink analyst Jonathan Chang maintains Kura Oncology (NASDAQ:KURA) with a Outperform and raises the price target from $40 to $41.

KURA

News

Ginkgo Bioworks Announces Purchase Of Epidemiological Data Infrastructure Assets

By Bill Haddad

Today, 5:56 AM

Transaction is expected to bolster Ginkgo's growing biosecurity platform and provide expanded epidemic tracking, modeling, and forecasting offerings to public health leaders and communities BOSTON, Aug. 19,

DNA

Lumen wins $1.5B Defense Information Systems Network contract

By Benzinga Newsdesk

Today, 5:56 AM

Lumen Technologies (NYSE:LUMN) has won a $1.5 billion contract from the Defense Information Systems Agency (DISA) to provide essential network transport and communications services in the U.S.

LUMN

Stifel Maintains Buy on Sea, Lowers Price Target to $105

Related Posts

Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition

SVB Leerink Maintains Outperform on Kura Oncology, Raises Price Target to $41

Ginkgo Bioworks Announces Purchase Of Epidemiological Data Infrastructure Assets

Lumen wins $1.5B Defense Information Systems Network contract